所有新聞和趨勢。

Expert knowledge on production under containment conditions.There is a great demand for information on innovative topics in the production of solid formulations. With its digital event titled “What’s Next? Containment Circle” on May 27, 2021, Fette Compacting offered a wealth of expert knowledge concerning the requirements on production under containment conditions.

Winner – Excellence in Business to Business Medical Technologies

Meet us @ ACHEMA Pulse!All June available with live experiences on 15-16 June 2021 Fette Compacting is part of the first ever #achemapulse!

What’s Next in OSD production: Containment the new standard!

In the form of its F30i, Fette Compacting will be launching the second tablet press of its new i Series on March 3, 2021. The high-performance double rotary press is optimized for two-layer tablets. It is also marked by its dust-tightness, containment capacity, system compatibility, and connectibility to Pharma 4.0.

The world has come closer together.“ Back to the roots, fit for the future: Joachim Dittrich has been Chief Executive Officer of Fette Compacting and a member of LMT Group executive management since January 2021. What links him to the company and the region and the plans he has for the future are disclosed in this interview.

Optimized for the future.In the form of its F30i, Fette Compacting is launching the second tablet press of its new i Series. Like the smaller F10i, it is also flexible, connectable, dust-tight, and system-compatible. In this interview, Thomas Friedrich, Director Product Management, and Jörg Gierds, Senior Product Manager, explain what makes these features so important.

Continuous Manufacturing is increasingly gaining in importance in the pharmaceutical industry. More and more oral solid dosage forms are manufactured by continuous production. In the form of direct compression, Fette Compacting is relying on the most efficient variant of continuous tablet production.

Schwarzenbek, December 14, 2020 – Mr. Karsten Kühl, CFO at Fette Compacting and Managing Director of LMT Finance & Shared Services, will be leaving the LMT Group at his own request by January 31, 2021.

True to the motto of “Lifetime Efficiency,” Fette Compacting supports companies along the entire life cycle of machines. From product design, selection of the ideal machine configuration, and ramp-up through adaptation on demand to continuous optimization, whereby the performance consultants are responsible for analyzing numerous parameters and machine settings – right through to the machine park as a whole. A project at the German subsidiary of a major pharmaceutical manufacturer uses existing processes as an example to show how many small and large measures can be applied to improve important production parameters and keep production efficient over the long term.

At its British site in Macclesfield, AstraZeneca produces three variants of one of it‘s leading breast cancer tablets. The company has increased its production volume on account of the increased demand worldwide. But the existing machine setup made it impossible to achieve the optimal output volume. Fette Compacting provided support in finding a solution and even succeeded in exceeding the set goals.

VR-Training at Boehringer Ingelheim. Boehringer Ingelheim is laying another foundation for innovative pharmaceuticals in the form of a new tablet factory. Thanks to VR training, personnel can be trained to handle containment even before the factory opens.

F10i – awarded with a "Special Mention"

Schwarzenbek, December 2, 2020 – The LMT Group has appointed Joachim Dittrich as Chief Executive Officer (CEO) of Fette Compacting and Member of the Management Board of the corporate group with effect from January 1, 2021.

Health and pleasure – on the advance worldwide